Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $20.78 in the prior trading day, Dyne Therapeutics Inc (NASDAQ: DYN) closed at $20.41, down -1.78%. In other words, the price has decreased by -$1.78 from its previous closing price. On the day, 0.92 million shares were traded. DYN stock price reached its highest trading level at $21.0 during the session, while it also had its lowest trading level at $20.26.
Ratios:
Our goal is to gain a better understanding of DYN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.47 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’25 when Kerr Douglas bought 880 shares for $20.72 per share.
Cox John bought 2,662 shares of DYN for $55,150 on Dec 05 ’25. On Dec 05 ’25, another insider, Cox John, who serves as the CEO & President of the company, sold 2,662 shares for $20.72 each. As a result, the insider received 55,157 and left with 196,877 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 3360552192 and an Enterprise Value of 2243630848.
Stock Price History:
The Beta on a monthly basis for DYN is 1.31, which has changed by -0.15079689 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, DYN has reached a high of $26.22, while it has fallen to a 52-week low of $6.36. The 50-Day Moving Average of the stock is 2.96%, while the 200-Day Moving Average is calculated to be 50.94%.
Shares Statistics:
The stock has traded on average 2.97M shares per day over the past 3-months and 3961500 shares per day over the last 10 days, according to various share statistics. A total of 142.61M shares are outstanding, with a floating share count of 118.92M. Insiders hold about 26.51% of the company’s shares, while institutions hold 73.77% stake in the company. Shares short for DYN as of 1764288000 were 17458619 with a Short Ratio of 5.88, compared to 1761868800 on 15118377. Therefore, it implies a Short% of Shares Outstanding of 17458619 and a Short% of Float of 13.639999999999999.
Earnings Estimates
A comprehensive evaluation of Dyne Therapeutics Inc (DYN) is underway, with the input of 10.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.65 and low estimates of -$1.0.
Analysts are recommending an EPS of between -$3.39 and -$3.83 for the fiscal current year, implying an average EPS of -$3.55. EPS for the following year is -$3.32, with 12.0 analysts recommending between -$2.73 and -$4.32.
